What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals will bring Lunit’s AI-powered…
Continue Reading
Gleneagles Hospital, part of the international private hospital group IHH Healthcare, has partnered with medical AI providers to bolster its diagnostics capability in Singapore and Hong Kong. On one hand, the radiology department at Gleneagles Hong…
Continue Reading
What You Should Know:
– Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
– The first-of-its-kind contribution will significantly enhance the NCI’s planned…
Continue Reading
Transforming breast cancer detection, ScreenPoint Medical’s Transpara Breast AI integrates seamlessly into Johns Hopkins Medicine’s renowned breast imaging services. This collaboration harnesses cutting-edge technology and clinical expertise to enhance screening accuracy and patient outcomes….
Continue Reading
Progress in sequencing technologies and clinical experiments has revolutionized immunotherapy on solid and hematologic malignancies. However, the benefits of immunotherapy are limited to specific patient subsets, posing challenges for broader application. To improve its…
Continue Reading
What You Should Know:
– The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC’s oncology care…
Continue Reading
What You Should Know:
– Thyme Care, a leader in value-based cancer care, has launched Thyme Care Oncology Partners (TCOP), a dedicated platform designed to support oncology practices in the transition to value-based care models.
–…
Continue Reading
By Shania Kennedy
March 13, 2024 – A research team from Washington University School of Medicine in St. Louis has developed a deep learning (DL)-based approach to help predict which patients with non-small cell lung cancer…
Continue Reading
Major EHR developers, including Epic and Oracle Health, have voluntarily committed to adopting USCDI+ Cancer, a recommended set of cancer-related data elements. This aligns with the Biden Cancer Moonshot’s aim to improve interoperability and…
Continue Reading
In a potential big advancement for oncology treatment and information sharing, several leading electronic health record vendors this week made voluntary commitment to adopt the United States Core Data for Interoperability Plus Cancer, or…
Continue Reading
